Chemoinformaics analysis of 2,3,5-Triethyl-2-cyclopentene-1-one
| Molecular Weight | 166.264 | nRot | 3 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 7 |
| Exact Molecular Weight | 166.136 | nRing | 1 |
| Solubility: LogS | -1.912 | nHRing | 0 |
| Solubility: LogP | 3.109 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 31.1743 |
| nHD | 0 | BPOL | 18.9257 |
| QED | 0.576 |
| Synth | 4.148 |
| Natural Product Likeliness | 1.387 |
| NR-PPAR-gamma | 0.28 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.246 |
| MDCK | 0.0000212 |
| BBB | 0.914 |
| PPB | 0.738904 |
| VDSS | 1.296 |
| FU | 0.186495 |
| CYP1A2-inh | 0.277 |
| CYP1A2-sub | 0.601 |
| CYP2c19-inh | 0.158 |
| CYP2c19-sub | 0.892 |
| CYP2c9-inh | 0.134 |
| CYP2c9-sub | 0.707 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.336 |
| CYP3a4-inh | 0.083 |
| CYP3a4-sub | 0.398 |
| CL | 12.858 |
| T12 | 0.725 |
| hERG | 0.005 |
| Ames | 0.015 |
| ROA | 0.476 |
| SkinSen | 0.061 |
| Carcinogencity | 0.54 |
| EI | 0.716 |
| Respiratory | 0.875 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.814432 |